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 Objective(s): To date, the most important genes responsible for tetracycline resistance among 
Acinetobacter baumannii isolates have been identified as tet A and tet B. This study was carried out 
to determine the rate of resistance to tetracycline and related antibiotics, and mechanisms of 
resistance. 
Materials and Methods: During the years 2010 and 2011, a total of 100 A. baumannii isolates were 
recovered from patients in different hospitals of Tehran, Iran. Antimicrobial susceptibility to 
tetracycline, minocycline, doxicycline and tigecycline was evaluated by E-test. Polymerase chain 
reaction (PCR) of the tet A and tet B genes was performed using specific primers, after which the 
isolates were subjected to Repetitive Extragenic Palindromic-PCR (PCR) to identify the major 
genotypes. 
Results: Of all isolates, 89% were resistant to tetracycline (MIC50 = 32 µg/ml, MIC90 = 512 µg/ml).  
Minocycline with the resistant rate of 35% (MIC50 = 16 µg/ml, MIC90 =32 µg/ml) and doxicycline 
with the resistant rate of 25% (MIC50 = 16 µg/ml, MIC90= 32 µg/ml) have a good activity against A. 
baumannii isolates. All isolates were sensitive to tigecycline. Frequencies of tet B and tet A genes 
and coexistence of tet A and tet B among the isolates resistant to tetracycline, were 87.6%, 2.2% and 
1.1%, respectively. Distribution of REP-types among A. baumannii isolates was types A (40%), B 
(30%), C (10%), D (5%) and E (5%). 
Conclusion: It seems that tet A and tet B genes play an important role in the induction of resistance 
towards tetracyclines used in this study. It is suggested that further studies focus on other 
antimicrobial drugs and combinations in order to achieve a successful therapy against multi drug 
resistance (MDR) A. baumannii strains in Iran. 
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Acinetobacter baumannii is the most clinically 
important species in the Acinetobacter genus that is 
involved in 1-2% of nosocomial pneumonia primarily 
in debilitated patients (1, 2). Infections due to A. 
baumannii, especially multi drug resistant strains, have 
been reported worldwide, so that only a few antibiotics 
have remained effective against MDR strains.  
Resistance against aminopenicillins, ureidop-
enicillins, cephalosporins, cephamycins, aminoglyc-
osides, chloramphenicol, tetracyclines, fluoroquinol-
ones and carbapenems were initially reported from 
different parts of the world (2). Tetracycline is a 
bacteriostatic antibiotic which inhibits protein 
synthesis by preventing the attachment of 
aminoacyl-tRNA to the ribosomal acceptor site. To 
date, the main mechanisms responsible for 
tetracycline resistance have been identified as (i) 
expression of efflux pumps and (ii) ribosomal 
protection. tet A and tet B are the most extensively 
characterized genes responsible for ribosomal 
protection. Although the distribution of many genes  
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responsible for resistance towards antimicrobial 
agents especially carbapenems and aminoglycosides, 
has been previously reported among A. baumannii 
isolates in Iran (3-12). 
There appears to be no comprehensive data 
concerning the mechanisms of resistance towards 
tetracycline and related antibiotics among A. 
baumannii isolates in this country. The aim of the 
present study was, therefore, to analyze the 
molecular mechanisms of resistance towards 
tetracycline and related antibiotics among clinical 
isolates of A. baumannii and to estimate the 
prevalence of the genetic constructs containing tet A 
and tet B genes in the isolates of this microorganism. 
Furthermore, the susceptibility of the isolates 
towards tigecycline (as a glycylcycline and a 
derivative of minocycline) and tetracyclines 
including tetracycline, minocycline and doxicycline 
was surveyed in this study. 
 
Materials and Methods 
Study population 
A total of 100 non-repetitive A. baumannii 
isolates were recovered in years 2010 and 2011 
from patients in different hospitals of Tehran, Iran. 
The isolates were non-repetitive, meaning that each 
isolate was obtained from a particular patient and 
each patient was sampled only once. These isolates 
were cultured from wounds (n = 40), the trachea (n = 
30), blood (n = 10), urine (n = 15), andcatheter (n = 
5). Strains were isolated mainly from patients in 
intensive care units (n = 36), burned ward (n = 30), 
internal ward (n = 20) and surgery (n = 4) from eight 
hospitals in Tehran, Iran. 
 All the isolates were identified as A. baumannii 
by the detection of blaOXA-51-like, an intrinsic and 
species specific gene, using API 20NE and 
biochemical testing according to those reported in 
previous reports (13). 
 
Antimicrobial susceptibility 
Using E-test, the susceptibility of all the isolates 
toward tetracycline, minocycline, doxicycline and 
tigecycline was tested. The isolates were then 
interpreted according to the manufacturer 
instructions and CLSI guidelines (14). Escherichia 
coli, ATCC 25922 and Pseudomonas aeruginosa, ATCC 
27852 were used as internal control. MIC 
interpretative standards for together tetracycline, 
minocycline and doxicycline was S: ≤ 4μg/ml, I: 8 
μg/ml and R: ≥16 μg/ml, respectively. The criteria 
defined by the US Food and Drug Administration 
(FDA) for Enterobacteriaceae were used for 
tigecycline (≤2, ≥4 μg/ml for susceptible and non 
susceptible strains, respectively) (15).  
 
DNA extraction 
Strains were maintained at -70°C in 80% /20% 
(v/v) glycerol in LB medium to preserve genetic 
variation during storage and were grown overnight 
on MacConkey agar at 37°C. DNA extraction was 
carried out by DNA Extraction kit (BIONER, Republic 
of Korea) in accordance with the manufacturer 
instructions. DNA was stored at -20°C until further 
use. 
 
PCR amplification of tet A and tet B genes  
The PCR products for tet A and tet B genes were 
considered presumptive positive based on amplicon 
sizes of 164bp and 206 bp, respectively. In the case 
of a negative PCR, PCR amplifications were repeated 
at least twice for these genes. A negative control was 
run along each PCR. 
The primer sequences included tet A (F: 5'-GCG 
CGATCTGGTTCACTCG-3'; R: 5'-AGTCGACAGYRGCG 
CCGGC-3') and tet B (F: 5'- CGTGAATTTATTGCTT 
CGG-3'; R: 5'-ATACAGCATCCAAAGCGCAC-3') (16). 
PCR were performed in a final volume of 25 μl 
containing 1X PCR buffer, 2 mM MgCl2, 2 mM dNTPs, 
10 pmol of primers, 0.25 U Taq DNA polymerase 
(Fermentas, UK) and 5 μl of template DNA. 
PCR conditions included 30 cycles of ampli-
fication under the following conditions: denaturation 
at 95°C for 30 s, annealing at 56°C for 1 min, and 
extension at 72°C for 1 min/kb product. Cycling was 
followed by a final extension at 72°C for 10 min. PCR 
products were resolved on 1.0% agarose gels, 
stained with ethidium bromide, and photographed 
with UV illumination. The 100-bp DNA ladder was 
used to assess PCR product size.  
 
REP-PCR  
All the isolates were subjected to REP-PCR 
typing method for finding common REP-types among 
all of the isolates. The primers used for REP-typing 
include F: 5'- IIIGCGCCGICATCAGGC-3' and R: 5'-
ACGTCTTATCAGGCCTAC- 3' (17). Amplification 
reaction was performed in a final volume of 25μl. 
The reaction contain 2.5 μl  of 10X PCR buffer, 1.25U 
Taq DNA polymerase (Fermentas, UK), 0.8 μl  of 2 
mM mixed dNTP,1.5 μl of 25 mM MgCl2, 1 μl of 10 
pmol of primers and 5 μl of template DNA. 
Amplification reaction was carried out by thermal 
cycler (Eppendorf, Germany) with an initial 
denaturation at 94°C for 10 min, followed by 30 
cycles of denaturation at 94°C for 1 min, annealing at 
45°C for 1 min, and extension at 72°C for 1 min, 
followed by final extension at 72°C for 16 min. 
Samples (20 µl) of each PCR end-product were 
analysed on agarose 2% wlv gels. 
 
Results 
Tigecycline, being effective against all tested A. 
baumannii isolates (100/100), was the most effective 
antimicrobial agent with the MIC50 = 0.125 µg/ml to 
MIC90 = 2 µg/ml. Resistance rate against doxicycline, 
minocycline and tetracycline was 18%, 19% and 
80%, respectively (Table 1, 2). Totally, 50 % (n = 
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Table 1. Antimicrobial susceptibility patterns of tetracycline and related antibiotic against Acinetobacter baumannii isolates 
 
 MIC vlues N (%) 
Antibiotics Ranges of MIC MIC50 (µg/ml) MIC90 (µg/ml) Sensitive Intermediate Resistant 
Tigecycline 0.125-2 0.5 2 100(100) 0 0 
Tetracycline 0.125-512 32 512 11 (11%) 9 (9%) 80 (80%) 
Minocycline 0.125-512 16 32 65 (65) 16 (16) 19(19) 
Doxicycline 0.125-512 16 32 75 (75) 7 (7) 18 (18) 
 
Table 2. MIC value of antibiotics against Acinetobacter baumannii isolates 
 
Antibiotics 
MIC diluted (µg/ml) 
0.125 0.25 0.5 1 2 4 8 16 32 64 128 256 512 
Tetracycline 1 0 0 2 4 4 9 19 19 5 2 5 26 
Minocycline 10 5 5 10 16 19 16 3 5 2 2 3 4 
Doxicycline 8 14 12 17 9 8 7 2 5 2 2 2 5 
Tigecycline 21 31 28 10 10 0 0 0 0 0 0 0 0 
 
Table 3. Distribution of tetracycline resistance genes among  Acinetobacter baumannii isolates regarding different antibiotics 
 
Antibiotics 
Tetracycline n (%) Minocycline n (%) Doxicycline n (%)  
I (n= 9) R (n=80) I (n=16) R (n=19) I  (n=7) R (n=18) 
Gene/s 
tet A 0 (0) 2 (2.5) 1 (6.25) 3 (15.7) 2 (28.5) 3 (16.6) 
tet B 4(44.4) 74 (83.1) 5 (31.2) 6 (31.5) 2 (28.5) 8 (44.4) 
tet A + tet B 0 (0) 1 (1.2) 5 (31.2) 5 (26.3) 2 (28.5) 4 (22.2) 
None 5 (55.5) 3 (3.7) 5 (31.2) 5 (26.3) 1 (14.2) 3 (16.6) 
       
 
50/100) and 4% (n = 4/100) of all the strains were 
only resistant to tetracycline and minocycline, 
respectively. Resistance rates of combinations of 
tetracycline + minocycline, tetracycline + minocy-
cline + doxicycline, tetracycline + doxicycline, and 
minocycline + doxicycline were 16% (n = 16/100), 
13% (n = 13/100), 10% (n = 10/100) and 2% (n = 
2/100), respectively.  Among the isolates, 4 (n = 
4/100; 4%) were sensitive to all the antibiotics used 
in this study whilst 96 (n = 96/100; 96%) were resis-
tant to at least one antibiotic among which 13 (n = 
13/96; 13.54%) were resistant to all the antibiotics 
used in this study. Among the resistant isolates, 36 (n 
= 36/96; 37.5%) were recovered from ICU, 30 from 
burns ward (n = 30/96; 31.2%), 20 from internal 
ward (n = 20/96; 20.8%) and 4(n = 4/96, 4.1%) from 
surgery ward, respectively. Nearly all tetracycline 
resistant isolates harbored at least one resistance 
gene (Table 3). Tet B was the most frequent encoding 
gene among tetracycline (n = 78/89; 87.6%), 
minocycline (n = 11/35; 31.4%) and doxicycline (n = 
10/25; 40%) resistant A. baumannii isolates (Table 
3). Coexistences of tet A + tet B was seen among 
1.1% (1 out of 80) of the tetracycline resistant  
isolates, 31.2% (5 out of 16) of the minocycline 
resistant and 44.4% (8 out of 18) of the doxicycline 
resistant A. baumannii isolates. According to Table 3 
less than 50% of intermediate isolates (intermediate 
resistance to tetracycline: 44.4%, intermediate resis-
tance to minocycline: 31.2% and intermediate re-
sistance to doxycycline: 28.5%) harbored tet B gene 
(Table 3). REP-PCR showed five clusters A, B, C, D 
and E with distribution rates of 40% (n = 40/100), 
30% (n = 30/100), 10% (n = 10/100), 5% (n = 
5/100) and 5% (5/100) among tetracycline resistant 
A. baumannii isolates, respectively. The REP patterns 
between ten A. baumannii isolates could not be dis-
tinguished by REP-fingerprinting (Dendrograme 1).  
 
Discussion 
The current study can be considered as the first 
comprehensive study evaluating tetracycline resis-tant 
A. baumannii isolates containing tet A and tet B 
resistance determinants in different hospital of Tehran, 
Iran.  
In most clinical practices, tetracyclines are not 
commonly used as treatments against A. baumannii 
infections due to the lack of data demonstrating their 
therapeutic efficacy. As a result, tetracycline resistance 
is not routinely monitored for multi-drug resistant A. 
baumannii and very few data are avail-able on the 
phenotypic and genotypic characteri-zation of 
resistance against these bacteriostatic agents among A. 
baumannii strains in Iran. Limited data was previously 
reported regarding tetracycline resistance among A. 
baumannii strains isolated from burn patients in one 
educational hospital in Tehran, Iran (6, 8, 12). The 
current study was, however, carried out in different 
hospitals and different samples.                                                                                                
Most of the A. baumannii strains in this study (n 
= 89/100; 89%) were tentatively classified as tetra-
cycline resistant based on an E-test (MIC50 = 32µg/ml 
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Dendrogram 1. Determination of different REP-types A, B, C, D and E among Acinetobacter baumannii isolates and their clonal 
relationships by Total Lab TL120 software. Advanced analysis of 1D gel electrophoresis gel images 
 
 
and MIC90 = 512µg/ml). Resistance of the isolates was 
subsequently confirmed by MIC values of ≥16 μg/ml, 
which is the proposed clinical breakpoint of CLSI to 
define resistance against tetracycline, minocycline 
and doxicycline.  
In this study, like the report from Iran (18), all of 
the isolates were sensitive to tigecycline, however, in 
recent reports from Iran, tetracycline resistant  A. 
baumannii isolates was reported from Tehran and 
Tabriz (15, 19). 
Tigecycline is a novel expanded broad-spectrum 
glycylcycline antibiotic that has a good activity 
against isolates which are either resistant and/or 
sensitive to tetracycline, minocycline and doxicyc-
line. It seems that the activity of tigecycline is not 
affected by the tetracycline resistance mechanisms 
described above. Although resistance to tigecycline 
is not seen among A. baumannii isolates, it has been 
recently shown that resistance against these 
antibiotics may exist due to the over expression of 
AdeABC efflux pump (20-22). Both tigecycline highly 
resistant and sensitive A. baumannii have been 
reported from all over the world (22, 23).   
Being highly resistant to tetracycline is common 
among A. baumannii isolates and the result of this 
study confirmed those data (24). 
 Activity of doxycycline in our Iranian A. 
baumannii isolates is in line with the reports from 
European countries. Mezzatesta and collageous also 
found that 94% of the isolates were sensitive to 
doxycycline (22).  
Likewise, Pei et al reported high degree of 
sensitivity to minocycline. We also found mino-
cycline has a moderate activity against A. baumannii 
isolates with the sensitivity rate of 65% (25). The 
result of Denis et al study which showed MDR A. 
baumannii isolates in USA, were susceptible to 
tigecycline and minocycline is in consistency with 
our results (26). 
The results, however, suggested a higher 
prevalence of the tet B gene among these clinical 
isolates (n = 78/89; 87.6%). 
 These results are consistent with those of Guar-
dabassi et al, who found that tet A and tet B are the 
genes responsible for tetracycline resistance (27). 
The results of this study, therefore, supports 
these data, since the tet A gene was identified in the 
strains resistant to tetracycline but not in those 
resistant to minocycline, whilst the gene was not 
found in the strains resistant to both antibiotics (28). 
These strains may possess the tet B determinant, 
which would confer with the resistance to both 
antibiotics. The genes tet A and tet B were not 
detected in 22 clinical isolates of tetracycline 
resistant A. baumannii. Tetracycline resistance in 
these isolates is probably due to other resistance 
genes and efflux pumps (29). REP-patterns could not 
be distinguished in ten of the isolates studied. 
Furthermore, only five clusters were identified 
among the A. baumannii isolates. Patterns of resis-
tance and distribution of tet A and tet B genes among 
different cluster were different. It seems that A. 
baumannii molecular typing via PCR-based methods 
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such as REP, could be beneficial in the differentiation 
of different strains of A. baumannii (30-33). 
Despite the increased frequency of multidrug 
resistance among the A. baumannii strains from Iran, 
only a little information exists regarding the 
antimicrobial resistance of this Gram negative 
bacillus in Tehran, Iran. The results of this study 
confirms those of the previous study which was 
carried out only on burn patients and which 
reported tet A and tet B as the most frequent 
mechanisms of tetracycline resistance among Iranian 
A. baumannii isolates. The identification of tet A and 
tet B in this study also confirms the wide 
geographical distribu-tion of these resistance genes 
among tetracycline resistant A. baumannii strains. 
The results show that surveillance for multidrug 
resistant A. baumannii should be maintained and 
careful infection control and cautious use of 
antibiotics must be taken into consideration. 
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